Background: Although on-treatment reactivity (OTR) while receiving clopidogrel is strongly associated with CYP2C19 genotype, the majority of the hereditability in clopidogrel response variability remains unexplained, supporting the contention that other important genetic determinants have yet to be identified. Whole exome sequencing -the sequencing of the entire protein-coding region of the genome -is a powerful, non-hypothesis driven approach that may identify novel loci associated with clinical traits.
